Technical Analysis for IMTX - Immatics N.V.

Grade Last Price % Change Price Change
F 10.37 0.10% 0.01
IMTX closed up 0.1 percent on Friday, March 5, 2021, on 1.8 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical IMTX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 0.10%
BB Squeeze Ended Range Expansion 0.10%
Below Lower BB Weakness 0.10%
Older End-of-Day Signals for IMTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago
2x Volume Pace 2 days ago
1.5x Volume Pace 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCER™). Its therapeutic approaches are ACTengine, Next Generation ACT, and TCER. The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Clinical Medicine Immune System Immunotherapy Treatment Of Cancer Cancer Treatments Virotherapy Immunotherapies Cell Therapy Adoptive Cell Transfer T Cell

Is IMTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.25
52 Week Low 8.665
Average Volume 135,467
200-Day Moving Average 0.00
50-Day Moving Average 10.90
20-Day Moving Average 11.08
10-Day Moving Average 10.84
Average True Range 0.51
ADX 14.03
+DI 14.64
-DI 23.24
Chandelier Exit (Long, 3 ATRs ) 10.18
Chandelier Exit (Short, 3 ATRs ) 11.82
Upper Bollinger Band 11.79
Lower Bollinger Band 10.38
Percent B (%b) -0.01
BandWidth 12.70
MACD Line -0.09
MACD Signal Line 0.01
MACD Histogram -0.0976
Fundamentals Value
Market Cap 652.36 Million
Num Shares 62.9 Million
EPS -0.08
Price-to-Earnings (P/E) Ratio -132.10
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.03
Resistance 3 (R3) 11.08 10.91 10.92
Resistance 2 (R2) 10.91 10.74 10.88 10.88
Resistance 1 (R1) 10.64 10.64 10.59 10.59 10.84
Pivot Point 10.47 10.47 10.45 10.45 10.47
Support 1 (S1) 10.20 10.30 10.15 10.15 9.90
Support 2 (S2) 10.03 10.20 10.01 9.86
Support 3 (S3) 9.76 10.03 9.82
Support 4 (S4) 9.71